This bipartisan legislation will help create a more transparent process that allows patients and physicians to seek exceptions to step therapy protocol. Although it only applies to employer-sponsored health plans, the bill represents an important step towards reining in this troubling practice.
An AHIP survey found that 73% of commercially-insured telehealth users think that Congress should make telehealth provisions permanent. These provisions were put in place to meet Americans' needs during Covid-19.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The law enacted by Congress in 2008, aims to remove insurance-related obstacles to mental health and substance use disorder treatment, but it hasn't been enforced effectively and there is a lack of oversight.
Drug prices are on the minds of patients and politicians. The November election is expected to tip the balance of power in Congress and a panel held during the Biotechnology Innovation Organization’s annual meeting discussed what that change could mean for drug price legislation.
Providers, health systems and patient groups who want to see telehealth survive beyond the federal public health emergency need to engage their lawmakers and associations now to demonstrate the need and utility for continued telemedicine.
Congress will have to debate whether pandemic era telehealth reimbursement and relaxation of rules should be made permanent. Given that those rules helped historically underserved populations access care as well as those seeking mental health services, experts believe there's too much to lose to simply go back to the old ways.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
In an unusual move, the Food and Drug Administration issued an alert about false negatives in startup Curative’s Covid-19 test. The test was being used by the County of Los Angeles, as well as Congress.
Congress finally reached an agreement on a $900 billion stimulus package, which includes a ban on surprise medical billing. A previous, but very similar version of the bill, raised concerns among providers and payers.
Congressional Democrats and Republicans introduced privacy bills that attempt to rein in what companies can do with data collected during the Covid-19 pandemic.
The House Education and Labor Committee advanced a bill to protect patients from surprise medical bills. A separate, rival bill from the House Ways and Means Committee is backed by hospitals and provider groups.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Rep. Chris Collins of New York was arrested last week for insider trading in shares of Australia's Innate Immunotherapeutics.
Insurers have until summer to decide if they want to continue to sell policies in the ACA marketplaces, but many start making preliminary decisions as early as April.
The Community Health Center program serves 27 million people at almost 10,000 nonprofit clinics nationwide, almost all of which are in low-income rural and urban areas.
A government shutdown will have far-reaching effects for public health, including the nation’s response to the current, difficult flu season. It will also disrupt some federally supported health services, experts said Friday.
Senate Democrats on Tuesday pressed President Donald Trump’s nominee for the top health post to explain how he would fight skyrocketing drug prices. Alex Azar is the former president of the U.S. division of Eli Lilly and Trump’s pick to run the Department of Health and Human Services,